Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp166 | Obesity (1) | ECE2019

Results from the phase 3 multicenter SONICS study of levoketoconazole: subgroup analysis of Cushing’s syndrome patients with diabetes mellitus

Fleseriu Maria , Pivonello Rosario , Elenkova Atanaska , Salvatori Roberto , Auchus Richard J. , Feelders Richard A. , Geer Eliza B. , Greenman Yona , Witek Przemyslaw , Cohen Frederic , Biller Beverly MK

Background: Cushing’s syndrome (CS) has numerous comorbidities, including diabetes mellitus (DM). Levoketoconazole is a ketoconazole stereoisomer in clinical trials for treatment of CS.Methods: SONICS is a prospective, open-label, phase 3 maintenance-of-benefit study in adults with confirmed CS and mean urinary free cortisol (mUFC) of ≥1.5x upper limit of normal (ULN). Repeated hospitalization due to hyperglycemia or any complication related t...

ea0063gp176 | Benign Thyroid Disorders | ECE2019

Do different initial doses of L-T4 within the range of 10–15 mcg/kg/die influence neurodevelopment during the first two years of life in children with congenital hypothyroidism?

Moracas Cristina , Ciccarelli Gian Paolo , Bravaccio Carmela , Cassio Alessandra , Gastaldi Roberto , Mussa Alessandro , Polizzi Miriam , Vigone Maria Cristina , Wasniewska Malgorzata Gabriela , Weber Giovanna , Salerno Mariacarolina

Background: The initial L-T4 dose in the treatment of congenital hypothyroidism (CH) currently recommended is 10–15 mcg/kg/die.Objective: We designed a multicenter randomized trial to evaluate the effects of different starting dose of L-T4 within the range 10–15 mcg/kg/die on neurocognitive development in children with CH.Methods: Seventy-two children with CH diagnosed by neonatal screening were enrolled in the study. The...

ea0063p981 | Diabetes, Obesity and Metabolism 3 | ECE2019

Effectiveness and tolerance of liraglutide and bupropión/naltrexone: clinical experience

Cardenas-Salas Jersy Jair , Luca Bogdana Luiza , Aliaga-Verdugo Alberto , Montoya-Alvarez Teresa , Gutierrez-Medina Sonsoles , Sierra-Poyatos Roberto , Sanz-Pastor Maria Alba Galdon , Martinez Clotilde Vazquez

Introduction: Different pharmacological therapies for obesity have become available in the last years. It is important to know their effectiveness in real-world practice and their acceptance among patients.Objectives: To analyze the anthropometric changes, daily dosis, side effects and treatment withdrawal in patients treated with Liraglutide or Naltrexone/Bupropion in clinical practice.Material and methods: Retrospective descripti...

ea0049oc6.2 | Diabetes therapy and complications | ECE2017

Insulin-mimetic effects of short-term Rapamycin in type 1 diabetic patients prior islet transplantation

Ermetici Federica , Briganti Silvia , Benedini Stefano , Codella Roberto , Maffi Paola , Caldara Rossana , Secchi Antonio , Piemonti Lorenzo , Alejandro Rodolfo , Ricordi Camillo , Luzi Livio

It has been suggested that the selective m-TOR inhibitor, Rapamycin, has been improved the success pancreatic islet allotransplantation (ITx) in type 1 diabetic patients (T1DM). Forty-one ITx were studied. Thirteen T1DM in poor glycemic control underwent a 45-days Rapamycin before ITx followed by standard Edmonton Protocol (EP, group 1, Milan), and they were compared to 28 T1DM patients undergoing EP (group 2, Miami). Outcome measures were daily insulin requirement (DIR), HbA1...

ea0049oc10.3 | Bone & Calcium Homeostasis | ECE2017

High prevalence of radiological vertebral fractures in patients with differentiated thyroid carcinoma undergoing L-thyroxine TSH-suppressive therapy

Formenti Anna Maria , Mazziotti Gherardo , Frara Stefano , Maffezzoni Filippo , Doga Mauro , Bertagna Francesco , Maroldi Roberto , Memo Maurizio , Giubbini Raffaele , Giustina Andrea

Thyroid hormones play a central role in the regulation of bone turnover and thyrotoxicosis is an established cause of secondary osteoporosis. Increased prevalence of reduced bone mineral density (BMD) has been reported even in patients with subclinical thyrotoxicosis such as those with differentiated thyroid carcinoma undergoing long-term L-thyroxine (L-T4) TSH-suppressive therapy. Morphometric vertebral fractures (VFs) are an early and clinically...

ea0049ep1118 | Female Reproduction | ECE2017

Influence of peroxisome proliferator-activated receptor (PPAR)-γ exon 2 (Pro12Ala) and exon 6 (His447His) and Gly972Arg insulin receptor substrate (IRS)-1 polymorphisms on insulin resistance (IR) and beta cell function in Southern Mediterranean women with polycystic ovary syndrome (PCOS)

Russo Giuseppina T , Pappalardo Maria Angela , Giandalia Annalisa , Romeo Elisabetta L , Alibrandi Angela , Bari Flavia Di , Vita Roberto , Cucinotta Domenico , Benvenga Salvatore

The Pro12Ala and His447His polymorphisms of PPAR-γ, and Gly972Arg polymorphism of IRS-1 have been implicated in insulin resistance (IR) and adiposity. In this study, we investigated the possible influence of these polymorphisms on metabolic features of 53 PCOS women compared with 26 healthy women (controls). All women underwent a clinical, anthropometric and biochemical evaluation, including a 75-g oral glucose tolerance test; insulin secretion and sensitivity indices wer...

ea0041gp210 | Thyroid - Translational & Clinical (1) | ECE2016

The expression of co-stimulatory receptor SLAMF-1 in lymphocytes from patients with autoimmune thyroiditis

Sampedro-Nunez Miguel , Vitales-Noyola Marlen , Serrano-Somavilla Ana , Di Pasquale Carmelina , Hernandez-Martinez Rebeca , Ramos-Levi Ana , Gonzalez-Amaro Roberto , Marazuela Monica

Introduction: Signalling lymphocytic activation molecule SLAMF1 (CD150) is a modulatory receptor expressed in most immune cells. Different data indicate that CD150 is involved in T cell cytokine production, NK cell and CD8 T cell mediated cytotoxicity, and T regulatory (Treg) cell activity. Patients with autoimmune thyroid disease (AITD) show defects in their immune-regulatory mechanisms. Herein we assessed the expression and function CD150 in lymphocytes subpopulations from p...

ea0041ep886 | Pituitary - Clinical | ECE2016

Radiological vertebral fractures in patients with acromegaly treated with L-thyroxine

Maffezzoni Filippo , Frara Stefano , Maria Formenti Anna , Mezzone Monica , Cerri Luigi , Porcelli Teresa , Doglietto Francesco , Maroldi Roberto , Mazziotti Gherardo , Giustina Andrea

Acromegaly is associated with skeletal fragility and high risk of vertebral fractures (VFs), but the determinants of such a risk are still under investigation and it is not clear whether replacement therapies of coexistent hypopituitarism may influence prevalence and incidence of VFs. In this cross sectional study, fourty acromegaly patients (24 M, 16 F; median age, 57 years; range, 25–72), 20 with active disease, were evaluated for the effects of replacement therapy of c...

ea0037gp.07.01 | Reproduction: Female and other | ECE2015

Preconceptional TSH and miscarriage in infertile women submitted to IVF

Vannucchi Guia , Covelli Danila , Renzini Mario , Brigante Claudio , Coticchio Giovanni , Canto Maria Beatrice Dal , Fadini Rubens , Dazzi Davide , Negro Roberto , Fugazzola Laura

It is known that high levels of TSH are associated with higher miscarriage risk, though the precise TSH cut-offs are debated. Aim of the present study was to evaluate if pre-conceptional TSH levels associate with increased risk of early miscarriage in a large series of infertile women submitted to IVF and to determine the threshold of TSH associated with the highest prevalence of pregnancy loss. We retrospectively studied 1484 infertile women (mean±age 36.7±4.1 years...

ea0037ep1066 | Thyroid (non-cancer) | ECE2015

A questionnaire on quality of life identifies Graves' ophthalmopathy patients who deserve more attention

Villagelin Danilo , Nogueira Heloisa , Sandrin Ana Claudia Gomes , Carbinatto Rebeca , Giovanetti Jakeline , Campos Larissa , Santos Roberto , Bufalo Natassia , Romaldini Joao , Ward Laura

Introduction: Graves’ ophthalmopathy (GO) varies from minor changes to visible face disfigurement which may compromise the visual capacity and the aesthetics of the patient. These deformities affect the quality of life in both functional and emotional senses. There are some questionnaires designed to evaluate the patient’s health, quality of life and relationship with a specific disease. The use of these questionnaires is recommended to improve the quality of care an...